Comparison of characteristics of outpatients with 2009 H1N1 pandemic and seasonal influenza

International Journal of Clinical Practice

Volumn 65, Issue 8, 2011, Pages 871-878

  Theocharis, G ^a   Vouloumanou, E K ^b   Barbas, S G ^a   Spiropoulos, T ^a   Rafailidis, P I ^b,c   Falagas, M E ^b,c,d  

^a SOS Doctors   (Greece)

^b ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^c HENRY DUNANT HOSPITAL   (Greece)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTITUSSIVE AGENT; ANTIVIRUS AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OSELTAMIVIR;

2009 H1N1 INFLUENZA; ADULT; ARTICLE; CLINICAL FEATURE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PANDEMIC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEASONAL INFLUENZA; VIRUS CULTURE;

ADOLESCENT; ADULT; AMBULATORY CARE; CHILD; CHILD, PRESCHOOL; FEMALE; GREECE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PANDEMICS; PATIENT ACCEPTANCE OF HEALTH CARE; RETROSPECTIVE STUDIES; SEASONS; YOUNG ADULT;

EID: 79960524710     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02684.x     Document Type: Article

References (30)

1. Chowell G, Bertozzi SM, Colchero MA, et al., Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009; 361: 674-9.
2. Falagas M, Koletsi P, Baskouta E, Rafailidis P, Dimopoulos G, Karageorgopoulos D,. 2009 (H1N1) pandemic influenza: review of the Southern hemisphere experience. Epidemiol Infect 2010; 139: 27-40.
3. Falagas ME, Cholevas NV, Kapaskelis AM, Vouloumanou EK, Michalopoulos A, Rafailidis PI,. Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the Northern Hemisphere. Eur J Clin Microbiol Infect Dis 2010; 29: 1327-47.
4. Plessa E, Diakakis P, Gardelis J, Thirios A, Koletsi P, Falagas ME,. Clinical features, risk factors, and complications among pediatric patients with pandemic influenza A (H1N1). Clin Pediatr (Phila) 2010; 49: 777-81.
5. Abanses JC, Dowd MD, Simon SD, Sharma V,. Impact of rapid influenza testing at triage on management of febrile infants and young children. Pediatr Emerg Care 2006; 22: 145-9.
6. Bonner AB, Monroe KW, Talley LI, Klasner AE, Kimberlin DW,. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics 2003; 112: 363-7. (Pubitemid 36951400)
7. Theocharis G, Vouloumanou EK, Rafailidis PI, Spiropoulos T, Barbas SG, Falagas ME,. Evaluation of a direct test for seasonal influenza in outpatients. Eur J Intern Med 2010; 21: 434-8.
8. Ginocchio CC, Zhang F, Manji R, et al., Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 2009; 45: 191-5.
9. Hawkes M, Richardson SE, Ipp M, Schuh S, Adachi D, Tran D,. Sensitivity of rapid influenza diagnostic testing for swine-origin 2009 a (H1N1) influenza virus in children. Pediatrics 2010; 125: e639-44.
10. Sandora TJ, Smole SC, Lee GM, Chung S, Williams L, McAdam AJ,. Test characteristics of commercial influenza assays for detecting pandemic influenza A (H1N1) in children. Pediatr Infect Dis J 2010; 29: 261-2.
11. Campanini G, Piralla A, Rovida F, et al., First case in Italy of acquired resistance to oseltamivir in an immunocompromised patient with influenza A/H1N1v infection. J Clin Virol 2010; 48: 220-2.
12. Falagas ME, Vouloumanou EK, Baskouta E, Rafailidis PI, Polyzos K, Rello J,. Treatment options for 2009 H1N1 influenza: evaluation of the published evidence. Int J Antimicrob Agents 2010; 35: 421-30.
13. Goldstein E, Cowling BJ, O'Hagan JJ, et al., Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009. BMC Infect Dis 2010; 10: 211.
14. Tramontana AR, George B, Hurt AC, et al., Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis 2010; 16: 1068-75.
15. Influ A&B Uni-Strip Product Information,.
16. Dean A, Sullivan K, Soe M,. OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version 2.2.1. Available from: (accessed September 2008).
17. Shiley KT, Nadolski G, Mickus T, Fishman NO, Lautenbach E,. Differences in the epidemiological characteristics and clinical outcomes of pandemic (H1N1) 2009 influenza, compared with seasonal influenza. Infect Control Hosp Epidemiol 2010; 31: 676-82.
18. Chang Y-S, van Hal SJ, Spencer PM, Gosbell IB, Collett PW,. Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenza and seasonal influenza during the "PROTECT" phase of the pandemic response. Med J Aust 2010; 192: 90-3.
19. Paine S, Mercer GN, Kelly PM, et al., Transmissibility of 2009 pandemic influenza A(H1N1) in New Zealand: effective reproduction number and influence of age, ethnicity and importations. Euro Surveill 2010; 15. pii: 19591.
20. Tang JW-T, Tambyah PA, Lai FYL, et al., Differing symptom patterns in early pandemic vs seasonal influenza infections. Arch Intern Med 2010; 170: 861-7.
21. Jeong I, Lee CH, Kim DK, Chung HS, Park SW,. Mild form of 2009 H1N1 influenza infection detected by active surveillance: implications for infection control. Am J Infect Control 2010; 38: 482-5.
22. McLean E, Pebody RG, Campbell C, et al., Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases. Epidemiol Infect 2010; 138: 1531-41.
23. Ciblak MA, Kanturvardar M, Asar S, Bozkaya E, Yenen OS, Badur S,. Sensitivity of rapid influenza antigen tests in the diagnosis of pandemic (H1N1)2009 compared with the standard rRT-PCR technique during the 2009 pandemic in Turkey. Scand J Infect Dis 2010; 42: 902-5.
24. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis - North Carolina, 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 969-72.
25. Chen H, Cheung CL, Tai H, et al., Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China. Emerg Infect Dis 2009; 15: 1970-2.
26. Gulland A,. First cases of spread of oseltamivir resistant swine flu between patients are reported in Wales. BMJ 2009; 339: b4975.
27. Falagas ME, Metaxas EI,. Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization. Expert Rev Anti Infect Ther 2009; 7: 913-23.
28. Falagas ME, Sideri G, Korbila IP, Vouloumanou EK, Papadatos JH, Kafetzis DA,. Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis. Pediatr Pulmonol 2010; 45: 1135-40.
29. Vardakas KZ, Matthaiou DK, Falagas ME,. Comparison of community-acquired pneumonia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus producing the Panton-Valentine leukocidin. Int J Tuberc Lung Dis 2009; 13: 1476-85.
30. Peppas G, Theocharis G, Karveli EA, Falagas ME,. An analysis of patient house calls in the area of Attica, Greece. BMC Health Serv Res 2006; 6: 112.